In early Thursday trading, shares of vision care company Alcon Inc. (ALC) declined 3.17% after the company raised its 2025 revenue outlook to $10.3-10.4 billion, driven primarily by strategic acquisitions and new product launches.
The company reported 3% sales growth in the second quarter, with a focus on expanding its eye care product portfolio. Alcon Inc.'s recent acquisitions and product launches are expected to strengthen its market position in the eye care industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.